BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33618181)

  • 1. Molecular mechanisms regulating lysophosphatidylcholine acyltransferase 1 (LPCAT1) in human pregnancy.
    Purandare N; Minchella P; Somayajulu M; Kramer KJ; Zhou J; Adekoya N; Welch RA; Grossman LI; Aras S; Recanati MA
    Placenta; 2021 Mar; 106():40-48. PubMed ID: 33618181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine acyltransferase 1 protein is present in maternal blood in the third trimester and is upregulated by antenatal corticosteroids.
    Kramer KJ; Purandare N; Aras S; Parsian F; Sadek S; Chao C; Welch RA; Recanati MA
    J Perinat Med; 2023 Mar; 51(3):432-434. PubMed ID: 36084307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPCAT1 levels in the placenta, the maternal plasma and the fetal plasma do not predict fetal lung responses to glucocorticoids in a sheep model of pregnancy.
    Takahashi T; Fee EL; Takahashi Y; Usuda H; Carter SWD; Ikeda H; Saito M; Kumagai Y; Bridges JP; Jobe AH; Choolani MA; Kemp MW
    Placenta; 2023 Jul; 138():1-9. PubMed ID: 37146534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis.
    Zou C; Ellis BM; Smith RM; Chen BB; Zhao Y; Mallampalli RK
    J Biol Chem; 2011 Aug; 286(32):28019-25. PubMed ID: 21685381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms.
    Aras S; Purandare N; Gladyck S; Somayajulu-Nitu M; Zhang K; Wallace DC; Grossman LI
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32056-32065. PubMed ID: 33257573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitochondrial regulator protein, MNRR1, is elevated in the maternal blood of women with preeclampsia.
    Suksai M; Romero R; Bosco M; Gotsch F; Jung E; Chaemsaithong P; Tarca AL; Gudicha DW; Gomez-Lopez N; Arenas-Hernandez M; Meyyazhagan A; Grossman LI; Aras S; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2297158. PubMed ID: 38220225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells.
    Tanosaki T; Mikami Y; Shindou H; Suzuki T; Hashidate-Yoshida T; Hosoki K; Kagawa S; Miyata J; Kabata H; Masaki K; Hamamoto R; Kage H; Miyashita N; Makita K; Matsuzaki H; Suzuki Y; Mitani A; Nagase T; Shimizu T; Fukunaga K
    Inflammation; 2022 Aug; 45(4):1765-1779. PubMed ID: 35338433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
    Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
    J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA:lysophosphatidylcholine acyltransferase I (LPCAT1).
    Zou C; Butler PL; Coon TA; Smith RM; Hammen G; Zhao Y; Chen BB; Mallampalli RK
    J Biol Chem; 2011 Jan; 286(4):2719-27. PubMed ID: 21068446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector-mediated delivery of lysophosphatidylcholine acyltransferase 1 attenuates airway inflammation in ovalbumin-induced allergic asthmatic mice.
    Cheng S; Chen H; Wang A; Xie M; Xie J; Osanai K; Zhao J; Xu Y; Xiong W; Zhou M
    Asian Pac J Allergy Immunol; 2015 Dec; 33(4):320-9. PubMed ID: 26708397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
    Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC
    Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells.
    Lin S; Ikegami M; Moon C; Naren AP; Shannon JM
    J Biol Chem; 2015 Jul; 290(30):18559-74. PubMed ID: 26048993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models.
    Nicholatos JW; Tran D; Liu Y; Hirst WD; Weihofen A
    Neurosci Lett; 2022 Feb; 772():136491. PubMed ID: 35108590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amniotic fluid LPCAT1 mRNA correlates with the lamellar body count.
    Welch RA; Shaw MK; Welch KC
    J Perinat Med; 2016 Jul; 44(5):531-2. PubMed ID: 25968427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HECTD2 Represses Cell Proliferation in Colorectal Cancer through Driving Ubiquitination and Degradation of LPCAT1].
    Ma L; Li DH; Xu Z
    Mol Biol (Mosk); 2022; 56(4):574-584. PubMed ID: 35964314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids.
    Akagi S; Kono N; Ariyama H; Shindou H; Shimizu T; Arai H
    FASEB J; 2016 May; 30(5):2027-39. PubMed ID: 26887439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
    Bellon E; Grupp K; Ghadban T; Tachezy M; Bachmann K; Izbicki JR; Simon R; Sauter G; Hube-Magg C; Melling N
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2879-2884. PubMed ID: 34148155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPCAT1 promotes melanoma cell proliferation via Akt signaling.
    Wang Y; Huang Y; Wang Y; Zhang W; Wang N; Bai R; Luo R; Tuo H; Zheng Y
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38551165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice.
    Dai X; Han J; Qi Y; Zhang H; Xiang L; Lv J; Li J; Deng WT; Chang B; Hauswirth WW; Pang JJ
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1724-34. PubMed ID: 24557352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.